Experimental drug DON aims to protect brains of children with cerebral malaria
Disease control
Recruiting now
This trial evaluates the safety of a single intravenous dose of DON, an experimental drug, in healthy adults, adults with uncomplicated malaria, and children aged 12 months to 14 years with cerebral malaria. Researchers will monitor side effects and measure how the drug moves thr…
Phase: PHASE1, PHASE2 • Sponsor: Douglas Postels, MD, MS • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC